Why the study?
Does radial artery access for PCI without interrupting oral anticoagulation improve safety (bleeding and thrombotic complications) in patients on chronic VKAs?
Does radial artery access for PCI without interrupting oral anticoagulation improve safety (bleeding and thrombotic complications) in patients on chronic VKAs?
Performing PCI via radial artery access without interrupting vitamin K antagonist therapy appears feasible and safe, avoiding the need for heparin bridging.
Answers are grounded in this paper and cite their sources.
Radial PCI without VKA interruption was associated with low early complications; leaves open randomized confirmation before practice change.
OBJECTIVES: To assess safety and feasibility of using radial artery access for percutaneous coronary intervention (PCI) in patients on oral anticoagulation without interrupting therapy. BACKGROUND: The radial artery approach for PCI is intuitively attractive for patients receiving chronic oral anticoagulation with vitamin K antagonists (VKAs) but little data exist concerning feasibility or safety of this approach in this population. The main advantage of this strategy would be to avoid bridging therapy with heparin that increases risk of thrombotic and bleeding events. METHODS: In this prospective observational study, 50 consecutive patients referred for coronary angiography underwent PCI without interrupting oral anticoagulant therapy. The main outcome measures were bleeding and thrombotic complications. RESULTS: The indications for permanent oral anticoagulation were as follows: atrial fibrillation in 62%, mechanical prosthesis in 24%, and venous thromboembolism in 14%. Seventy-two percent were elective cases and 28% presented with acute coronary syndromes. PCI was performed with an INR range of 1.4-3.4 with mean of 2.2 +/- 0.6. Seventy-six percent of the patients were on dual antiplatelet therapy before the procedure. No thrombotic events or excess bleeding were observed at 1 month. Only one patient had a minor hemorrhage 8 days after procedure. CONCLUSIONS: This series suggests that for patients treated with VKAs, the use of radial artery access is feasible and safe for PCI on dual antiplatelet therapy without interrupting oral anticoagulant treatment.
No takes yet. Share an insight, caveat, or question.
Helft et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: